Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Am J Clin Nutr ; 85(4): 972-80, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17413095

RESUMO

BACKGROUND: Weight loss is associated with bone loss, but this has not been examined in overweight premenopausal women. OBJECTIVE: The aim of this study was to assess whether overweight premenopausal women lose bone with moderate weight loss at recommended or higher than recommended calcium intakes. DESIGN: Overweight premenopausal women [n = 44; x (+/-SD) age: 38 +/- 6.4 y; body mass index (BMI): 27.7 +/- 2.1 kg/m(2)] were randomly assigned to either a normal (1 g/d) or high (1.8 g/d) calcium intake during 6 mo of energy restriction [weight loss (WL) groups] or were recruited for weight maintenance at 1 g Ca/d intake. Regional bone mineral density and content were measured by dual-energy X-ray absorptiometry, and markers of bone turnover were measured before and after weight loss. True fractional calcium absorption (TFCA) was measured at baseline and during caloric restriction by using a dual-stable calcium isotope method. RESULTS: The WL groups lost 7.2 +/- 3.3% of initial body weight. No significant decrease in BMD or rise in bone turnover was observed with weight loss at normal or high calcium intake. The group that consumed high calcium showed a strong relation (r = 0.71) between increased femoral neck bone mineral density and increased serum 25-hydroxyvitamin D. No significant effect of weight loss on TFCA was observed, and the total calcium absorbed was adequate at 238 +/- 81 and 310 +/- 91 mg/d for the normal- and high-calcium WL groups, respectively. CONCLUSION: Overweight premenopausal women do not lose bone during weight loss at the recommended calcium intake, which may be explained by sufficient amounts of absorbed calcium.


Assuntos
Conservadores da Densidade Óssea/administração & dosagem , Densidade Óssea/efeitos dos fármacos , Cálcio da Dieta/administração & dosagem , Obesidade/dietoterapia , Pré-Menopausa , Redução de Peso/fisiologia , Absorciometria de Fóton , Adulto , Composição Corporal/fisiologia , Densidade Óssea/fisiologia , Conservadores da Densidade Óssea/farmacocinética , Osso e Ossos/efeitos dos fármacos , Osso e Ossos/metabolismo , Cálcio da Dieta/farmacocinética , Dieta Redutora , Relação Dose-Resposta a Droga , Feminino , Humanos , Absorção Intestinal , Pessoa de Meia-Idade , Obesidade/sangue , Hormônio Paratireóideo/sangue , Pré-Menopausa/fisiologia , Vitamina D/análogos & derivados , Vitamina D/sangue
2.
Menopause ; 21(5): 501-8, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24149920

RESUMO

OBJECTIVE: Short-term weight loss is accompanied by bone loss in postmenopausal women. The longer-term impact of weight loss on bone in reduced overweight/obese women compared with women who regained their weight was examined in this study using a case-control design. METHODS: Postmenopausal women (N = 42; mean [SD] body mass index, 28.3 [2.8] kg/m; mean [SD] age, 60.7 [5.5] y) were recruited 2 years after the start of a 6-month weight loss trial; those who maintained their weight (weight loss maintainer [WL-M] group) were matched to a cohort of women who regained their weight (weight loss regainer [WL-R] group). Serum hormones and bone markers were measured in a subset. Bone mineral density (BMD) at the femoral neck, trochanter, spine, radius, and total body, and soft-tissue composition were taken at baseline, 0.5 years, and 2 years. RESULTS: During weight loss, both groups lost 9.3% (3.4%) of body weight, with no significant difference between the groups. After weight loss, weight change was -0.1% (2.7%) and 6.0% (3.3%) in the WL-M (n = 22) and WL-R (n = 20) groups, respectively. After 2 years, both groups lost BMD at the femoral neck and trochanter (P ≤ 0.01), whereas only the WL-M group reduced BMD at the 1/3 radius (P < 0.001). There was greater BMD loss at the trochanter (-6.8% [5.7%]) and 1/3 radius (-4.5% [3.3%]) in the WL-M group compared with the WL-R group after 2 years. Multiple linear regression showed that change in leg fat mass (but not trunk fat) contributed to trochanter BMD loss (P < 0.05). CONCLUSIONS: After 2 years, there is no BMD recovery of weight reduction-induced bone loss, irrespective of weight regain. These data suggest that the period after weight loss may be an important point in time to prevent bone loss for those who maintain weight and those who regain weight.


Assuntos
Densidade Óssea/fisiologia , Pós-Menopausa/fisiologia , Aumento de Peso/fisiologia , Redução de Peso/fisiologia , Adulto , Composição Corporal/fisiologia , Estudos de Casos e Controles , Feminino , Fêmur/fisiologia , Colo do Fêmur/fisiologia , Humanos , Pessoa de Meia-Idade , Rádio (Anatomia)/fisiologia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa